Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong
· Delayed Price · Currency is HKD 3.380
+0.040 (1.20%)
Apr 29, 2026, 4:08 PM HKT
Hua Medicine (Shanghai) Revenue
In the year 2025, Hua Medicine (Shanghai) had annual revenue of 492.93M CNY with 92.63% growth. Hua Medicine (Shanghai) had revenue of 275.50M in the half year ending December 31, 2025, with 4,287.67% growth.
Revenue
492.93M CNY
Revenue Growth
+92.63%
P/S Ratio
6.14
Revenue / Employee
1.50M CNY
Employees
328
Market Cap
3.37B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Golden Throat Holdings Group Company | 1.05B |
| VISEN Pharmaceuticals | 151.34K |
| Jacobson Pharma Corporation | 1.53B |
| JBM (Healthcare) | 812.98M |
| Essex Bio-Technology | 1.81B |
| Chia Tai Enterprises International | 4.17B |
| Beijing Tong Ren Tang Chinese Medicine Company | 1.51B |
| Dawnrays Pharmaceutical (Holdings) | 1.37B |
Hua Medicine (Shanghai) News
- 4 weeks ago - Hua Medicine (Shanghai) Earnings Call Transcript: H2 2025 - Transcripts
- 8 months ago - Hua Medicine (Shanghai) Earnings Call Transcript: H1 2025 - Transcripts
- 1 year ago - Hua Medicine (Shanghai) Earnings Call Transcript: H2 2024 - Transcripts
- 2 years ago - Hua Medicine (Shanghai) Earnings Call Transcript: H1 2023 - Transcripts
- 3 years ago - Hua Medicine (Shanghai) Earnings Call Transcript: H2 2022 - Transcripts
- 4 years ago - Hua Medicine (Shanghai) Earnings Call Transcript: H2 2021 - Transcripts
- 5 years ago - Hua Medicine (Shanghai) Earnings Call Transcript: H1 2021 - Transcripts
- 6 years ago - Hua Medicine (Shanghai) Transcript: UBS Virtual Global Healthcare Conference - Transcripts